Drug Shortage Report for PRALUENT
Report ID | 137220 |
Drug Identification Number | 02453835 |
Brand name | PRALUENT |
Common or Proper name | Praluent |
Company Name | SANOFI-AVENTIS CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | ALIROCUMAB |
Strength(s) | 150MG |
Dosage form(s) | SOLUTION |
Route of administration | SUBCUTANEOUS SUBCUTANEOUS |
Packaging size | 2 |
ATC code | C10AX |
ATC description | LIPID MODIFYING AGENTS, PLAIN |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | 2021-04-29 |
Actual start date | |
Estimated end date | 2021-05-14 |
Actual end date | 2021-05-03 |
Shortage status | Resolved |
Updated date | 2021-05-04 |
Company comments | A manufacturing delay may create a short term shortage. Supplies are expected by early May, shortage should be avoided as allocation will be put in place. |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2021-04-09 | English | Compare |
v2 | 2021-04-09 | French | Compare |
v3 | 2021-04-09 | English | Compare |
v4 | 2021-04-09 | French | Compare |
v5 | 2021-04-30 | English | Compare |
v6 | 2021-05-04 | English | Compare |
v7 | 2021-05-04 | French | Compare |
Showing 1 to 7 of 7